Cell cycle withdrawal involves several transcription factors such as E2Fs members that play a key role in cell growth control. Here we describe a novel putative bZIP transcription factor isolated from the retina and involved in neuronal proliferation arrest at the terminal dierentiation: PATF (Proliferation Arrest Transcription Factor). We show that PATF associates with E2F4 protein and interacts with the E2F consensus site. PATF expression increases with establishment of quiescent state. Furthermore, the nuclear PATF localization like E2F4, depends on cell growth arrest. The decrease of PATF amount, using a retroviral antisense strategy, results in pursued neuroretina cell mitosis. Our results indicate that PATF could be a new molecular signal implicated in the ®nal neuronal cell cycle withdrawal. Oncogene (2001) 20, 5475 ± 5483.
Introduction
The development of the vertebrate retina involves the evolution of undierentiated actively proliferating neuroepithelial cells into adult neuronal and glial cell types, in a stable postmitotic state at the onset of dierentiation (Crisanti-Combes et al., 1977) . Numerous studies have investigated the transition from cell proliferation to a de®nitive postmitotic status, but the molecular mechanism is not completely understood. Many transcription factors play a fundamental role in the regulation of proliferation and dierentiation in neural development (Olson, 1990; He and Rosenfeld, 1991; Struhl, 1991; Wang and Adler, 1994) . The E2F (adenoviral E2 promoter activator factor) transcription factors, regulate the correct timing of genes activation, involved in cell proliferation and DNA replication (Slansky and Farnham, 1996; Helin, 1998; Yamasaki, 1998) . Heterodimers composed of E2F and DP (dimerization partner) family members form stable trimeric complexes with Rb proteins (Wu et al., 1995; Nevins, 1998) . Disruption of these interactions promotes cell proliferation and, conversely, their stabilization inhibits cell growth. The E2F family can be divided into three groups. The ®rst group, including E2F-1, E2F-2, E2F-3a (Leone et al., 2000) is tightly coupled to cell proliferation since they are not expressed in quiescent cells. In contrast, the second group, including E2F-3b (Leone et al., 2000) , E2F-4, E2F-5, is not regulated by cell growth and appears to be involved in cell growth arrest and/or dierentiation. The third group contains only E2F-6, which represses the transcription of E2F responsive genes, counteracting the activity of the other E2F complexes via a mechanism independent of pRb family (Trimarchi et al., 1998) . In neuroretina, at the onset of development, E2F1 expression is downregulated . In this post mitotic neuroretina, the E2F1/pRb complex disappears followed by the formation of E2F4/p130 complex (Kastner et al., 1998) .
Here we study the characterization of the PATF cDNA which encodes a new member of the basicleucine zipper (bzip) transcription factor family. PATF is expressed in dierent tissues including the retinas of quail, chick, mouse and rabbit, and in various neuronal cell lines. PATF associates with E2F4 and during development, its expression and cellular localization are similar to those observed for E2F4, suggesting that both molecules are involved in the same pathway, regulating the cell cycle. This new complex PATF/ E2F4 might be a critical regulator in the negative control of cell proliferation.
Results

PATF was isolated from quiescent retina cells
The PATF isolation experiments were initially designed to identify genes speci®cally expressed at the onset of neuronal cell cycle withdrawal that might be involved in terminal mitosis or in the dierentiation of neuroretina (NR) cells. We assumed that the transcription of such genes would be downregulated when these non-dividing cells were induced to proliferate. Therefore, we constructed an auto-subtracted cDNA library, as previously described (Bidou et al., 1993) , using mRNA from a quiescent retinal cell clone against an excess of mRNA from the same clone, but in active proliferation. Twenty of the 8300 recombinant clones were selected as speci®cally expressed in the postmitotic state. In this study, we characterize one such clone: the PATF cDNA.
PATF sequence exhibited characteristics of a transcription factor
A library prepared with total mRNA from neuroretinas of 2-day-old quails was screened with the PATF cDNA isolated from the subtracted library. The sequence obtained was 2196 bp long and contained the full-length 831 bp open reading frame ( Figure 1A ). Primary structure analysis and comparison with database sequences indicated that PATF nucleotide sequence had no signi®cant similarity to listed sequences. The deduced amino acid sequence corresponds to a protein of 277 amino acids ( Figure 1B ). The PATF protein contains a leucine zipper motif at the N-terminus, a basic domain containing a nuclear localization sequence (NLS) at the C-terminus.
PATF expression parallels the quiescent state establishment PATF mRNA expression To determine the pattern of PATF mRNA expression during chick retinal development, four stages, E5, E8, E15 and 7 days posthatching were assessed by Northern blot analysis. Only one transcript (6.8 ± 7 kb) was detected ( Figure 2A ). The amount of PATF mRNA increased by E8, E15 and 7 days post-hatching, in parallel with the establishment of the quiescent state. We investigated by RT ± PCR whether PATF mRNA was also present in adult mammalian tissues ( Figure 2B ). PATF mRNA was detected in rabbit and mouse retinas, as well as in brain, spleen, thymus, cerebellum and liver. No PATF mRNA was detected in the embryonic mouse central nervous system at E15 ( Figure 2B , lane 7).
PATF protein expression Total protein extracts from retinas at various stages of development between E8 and 7 days post-hatching were analysed by Western blotting. As shown in Figure 3A , using anti-PATF antibody (I), a clear signal was detected with an apparent molecular weight of 50 kDa. A faint signal was present at E5, E8 and E10. PATF protein levels increased on E11, reaching a maximum at E12, when cells became postmitotic, and remaining at this level until the end of the development. No signi®cant speci®c immunoreactivity was detected in the control experiments performed with the preimmune serum (PI). As expected, PATF protein was also detected in nuclear extracts and the PATF signal was stronger in quiescent neuroretina at E17 than in proliferating retina at E5 ( Figure 3B ). Thus PATF expression closely parallels the establishment of the quiescent state, suggesting an important role for this new gene in the control of cell proliferation.
Localization of PATF in chick neuroretina
We investigated the localization of PATF protein in cryosections of chick neuroretina at two stages of embryogenesis, with the anti-PATF serum ( Figure 4A ). In the early stage of development, E5 retinas were not yet dierentiated or organized into layers and most of the cells were in mitosis. At this stage, PATF staining was restricted to a few cells and the signal was essentially limited to the cytoplasm. Retinas from E17 were de®nitively organized and all the cells were postmitotic. PATF expression became widespread in all retinal layers, with fainter staining in the outer nuclear layer, which consists of photoreceptor cells. The signal became more intense and was restricted to the nucleus of many cells in all cell layers. The distribution of PATF in mouse retina was similar to that described for chick retina (data not shown). The pattern of staining was similar in equivalent cell layers. To con®rm this result, chick retinas at the indicated stages were dissociated and used for PATF localization ( Figure  4A ). At E5, cells exhibited mainly cytoplasmic PATF staining while at E17, when cells were postmitotic, PATF labeling was furthermore observed in the nucleus.
PATF is expressed and localized in the cytoplasm of established neuronal cell lines
To determine whether PATF was present in established neuronal cell lines, we performed immunocytochemistry experiments on PC12 rat pheochromocytoma cells, human SH-SY5Y neuroblastoma cells and Y79 retinoblastoma cells ( Figure 4B ). As expected, PATF protein was detected exclusively in the cytoplasm and no nuclear labeling was observed. When PC12 cells were treated with NGF, which induces growth arrest and cell dierentiation, PATF was detected in both the cytoplasm and nucleus. These results point to the importance of the nuclear localization of PATF in proliferation arrest upon NGF cell dierentiation ( Figure 4C ).
Role of PATF in the control of cell proliferation using a retroviral antisense strategy
In vitro experiments Primary retina cell cultures were infected with RCAS (replication-competent avian retrovirus vector) alone or containing a part of PATF sequence in sense or antisense orientation. Immunocytochemistry was performed to assess PATF expression, cell mitosis (BrdU) and viral infection (p27 gag). No PATF immunoreactivity was observed with the preimmune serum ( Figure 5A ,a). In Figure 5A ,b, PATF immunoreactivity was signi®cantly decreased in cells infected with the antisense RCAS construct (AS) compared to the control RCAS or sense RCAS-infected cells (RCAS, S). Ten days after infection, no S phase was detected in RCAS alone or in sense RCAS-infected cells ( Figure 5A ,c), whereas, in antisense infected cultures, we observed foci of cells clearly stained with the anti-BrdU antibody ( Figure 5A ,c AS). Identical p27 gag signals were detected in cells infected with RCAS alone, sense (S) or antisense (AS) RCAS constructs, attesting a similar viral infection ( Figure 5A,d ).
To determine the proportion of cells in S phase, we performed quanti®cation of BrdU positive cells from 6-day-old retina primary cultures infected cells with S-or AS-RCAS. Three days after infection, the percentage of BrdU positive cells was higher by 20% in AS-RCAS versus S-RCAS infected cells. Ten days after infection, no S phase was detected in sense infected cells, while 6% of total cells were BrdU positive in antisense Figure 5B ). These results suggest that the decrease of PATF expression leads to an extensive number of cells in S phase and thus prevents the cell cycle withdrawal beyond the normal period of retina proliferation.
Western blot analysis con®rmed that PATF expression in AS-RCAS infected cells was reduced by threefold compared to that observed in S-RCAS infected cells ( Figure 5C ).
In vivo experiments Ten days after virus injection, we studied eye cryosections histologically. Viral infection was tested with p27 gag antibody (data not shown). Eyes injected with the antisense RCAS construct showed retinal dysplasia. These morphological abnormalities were reproducible, since they were observed in ®ve series of independent experiments. The morphological changes observed consisted mostly of rosette formation ( Figure 5D ,b) and PATF transcript signal is stronger at E15, when neuroretina cells are postmitotic. One transcript (6.8 ± 7 kb) was detected. (B) RT ± PCR analysis of PATF was performed in mammalian tissues: mouse retina (1), rabbit retina (2), mouse brain (3), mouse spleen (4), mouse thymus (5), mouse cerebellum (6), mouse central nervous system at E15 (7), mouse liver (8). The 160 bp transcript for GAPDH was used to normalize levels of RNAs Figure 3 Expression of PATF protein during chick development. (A) Protein extracts from chick retina at the indicated stages were immunoblotted with anti-PATF antibody (I), preimmune serum (PI) and a tubulin, respectively. PATF signal was detected at E5 and remained at a low level during proliferation (E5, E8, E10 and E11). The PATF signal was more intense in postmitotic retinas (E12, E15 and P7). No signal was detected with the preimmune serum (PI). (B) Anti-PATF antibody was used to probe protein from nuclear extracts in retina tissues at E5 and E17. Note that PATF staining was more intense in the nucleus at E17 than at E5 Figure 4 Localization of PATF by confocal immuno¯uorescence in chick neuroretina and various neuronal cell lines. (A) Cryostat retina sections and the corresponding retina cell suspensions, at E5 and E17 were stained with anti-PATF (green) and nuclear staining with propidium iodide (red). PATF within the nucleus is shown by the yellow staining. ONL: outer nuclear layer, INL: inner nuclear layer, IPL: inner plexiform layer, GCL: ganglion cell layer. PATF staining becomes progressively nuclear (yellow uorescence) at E17, when cells are quiescent. Control was performed on E17 retina sections with preimmune serum. (B) PATF labeling is faint and exclusively cytoplasmic in PC12, SH-SY5Y and Y79 cells, consistent with these cell lines being in active proliferation. (C) Upon dierentiation of PC12 cells by NGF treatment, the nuclei became PATF stained retinal infolding ( Figure 5D ,c). They resulted in loss of the normal architecture of the tissue. Eyes injected with the sense RCAS construct had normal morphology ( Figure 5D,a) . These results, obtained using an antisense strategy in vitro and in vivo, demonstrate that PATF plays a major role during development.
PATF associates with E2F4
We investigated the ability of PATF to interact with proteins involved in the cell cycle machinery, by carrying out coimmunoprecipitations with protein extract from E17 retinas, using anti-PATF, anti-E2F1 and anti-E2F4 antibodies. The immunocomplexes obtained were further subjected to Western blot analysis with the same antibodies ( Figure 6A ). No signi®cant signal was obtained for the immunocomplex precipitated with anti-E2F1 antibody, or with preimmune serum (PI), whereas a clear signal was detected for immunocomplexes obtained with anti-E2F4 or PATF antibodies. The Figure 6B presents Western blot experiments on E17 retinal nuclear extracts using E2F4 and PATF antibodies preincubated with or without PATF immunizing peptides. Both antibodies gave speci®c immunoreactive bands with distinct molecular weights. No PATF immunoreactivity was detected when PATF antiserum was preincubated with immunizing peptides. In parallel, E2F4 antibody preincubation with PATF peptides did not aect E2F4 immunoreactivity. Immunohistochemical study of E2F4 expression ( Figure 6C ) showed that distribution of E2F4 during the development was similar to that reported for PATF in Figure 4B . Indeed, E2F4 like PATF, has a nuclear localization in quiescent retina cells. Thus E2F4, but not E2F1, associates with PATF.
PATF down regulation parallels E2Fs target genes activation
To determine whether the physical interaction between PATF and E2F4 was functionally involved in the establishment of the quiescent state, we tested the eect of PATF expression on activation of two E2F target genes: dihydrofolate reductase (DHFR) and DNA polymerase a (DNA POLa). We ®rst compared the expression of PATF, E2F4 and E2F1 in retina from E5 (growing cells) and E17 (quiescent cells). At E17, the expression of both PATF and E2F4 was strongly increased, compared to that at E5, and conversely E2F1 expression disappeared at E17 ( Figure 7A ). To study the eect of PATF decrease on E2Fs target genes activation, we used the RCAS antisense strategy, in primary cultures. In these infected cells, Western blot analysis con®rmed the decrease of PATF protein and also showed in parallel, E2F4 down-expression and E2F1 level increase ( Figure 7B ). In these cultures, RT ± PCR analysis clearly demonstrated that DHFR and DNA POLa RNAs level was signi®cantly higher than those of the control ( Figure 7C ). These results suggest that PATF is functionally involved in the mechanisms of E2F1 regulation. 
Interaction between PATF and the E2F consensus site
As we have demonstrated by immunoprecipitation that PATF is associated with E2F4 and we have shown that PATF expression could regulate E2F target genes, we investigated whether PATF interacts with the E2F consensus site. This interaction was tested in electromobility shift assays (EMSAs) using nuclear protein extracts from E17 retina (Figure 8 ). In these experiments, we used in parallel C/EBP (lanes 1 ± 3) and E2F probes (lanes 4 ± 8 and lanes 4 ± 6). Speci®c C/EBP-DNA and E2F/DNA relevant complexes are noted in the ®gure. The complexes indicated as the symbol * in Figure 8 could account for non-speci®c labeling or for free C/EBP or E2F. The PATF polyclonal antiserum was tested for its ability to supershift the speci®c complexes. As shown Figure 8 , lane 6, the PATF antiserum speci®cally recognizes the E2F/PATF/DNA bound complex. No supershift was observed with C/ EBP probe (lane 3). Binding speci®city was tested using dierent controls: unlabeled oligonucleotides as competitors (lanes 2 and 5), PATF pre-immune serum (lane 7) and another anti-rabbit polyclonal antibody, against glial ®brillary acidic protein (anti-GFAP) (lane 8).
Discussion
Here we describe a new gene PATF, involved in the negative control of cell proliferation. PATF was Figure 6 Protein interactions between PATF and members of the E2F family. (A) Immunoprecipitation analysis performed with E17 retina protein extracts. Lysates were immunoprecipitated with preimmune serum PI, anti-PATF, anti-E2F1 and anti-E2F4 antibodies. The resulting complexes were then probed with anti-PATF, anti-E2F4 and anti-E2F1 antibodies respectively. Note that PATF was observed in immunoprecipitation complexes obtained by anti-E2F4, and not by E2F1. Conversely only E2F4 was detected in immunoprecipitation complexes obtained by anti-PATF. (B) Western blot experiments on E17 retinal nuclear extracts using E2F4 and PATF antibodies preincubated without (7) or with (+) PATF immunizing peptides. (C) Immunohistochemical detection of E2F4 during development: E2F4 was present in the cytoplasm at E8, whereas E2F4 displayed a nuclear localization similar to PATF at E17. Control was from E17 retina cell suspensions with preimmune serum Figure 7 Functional interaction of PATF with E2Fs. PATF, E2F4, E2F1 and a-tubulin protein expressions: (A) in retina at E5 (proliferating tissue) and E17 (quiescent tissue), (B) in primary cell cultures infected with sense (S) or antisense (AS) RCAS constructs. Note the strong increase in PATF and E2F4 expressions at E17, while E2F1 is detected only at E5. In antisense RCAS-infected cells, the lower expression of PATF protein parallels with E2F4 decreased with higher level of E2F1. (C) RT ± PCR analysis of two E2F1 target genes, dihydrofolate reductase (DHFR) and DNA polymerase a (DNA POL a), performed in infected primary culture cells. Both genes are upregulated in AS infected cells. GAPDH signal is used to normalize RNA levels isolated using a subtractive cDNA library approach between quiescent and active proliferating retinal cell clone (Bidou et al., 1993) . PATF has the characteristics of a transcription factor with a leucine zipper motif, a basic domain and a nuclear localization sequence. PATF expression in the retina gradually increases during retinal development in parallel with establishment of the quiescent state and dierentiation. The translocation of PATF to the nucleus clearly correlates with proliferation arrest indicating that its subcellular localization depends on proliferative or quiescent state of the cells. We investigated the involvement of PATF in neuronal growth arrest using an RCAS retroviral antisense strategy. In vitro, the decrease of PATF protein by the antisense strategy caused additional mitosis in primary cell cultures consistent with the implication of PATF in neuronal cell cycle withdrawal. The arrest of cell proliferation, beyond the normal period of retina proliferation, is due to a combination of several cell cycle inhibitors and the inhibition of only one of these factors is not sucient to permit the long-term proliferation. The most probable explanation, is the existence of compensatory mechanisms which lead to extended cell divisions before dierentiation (Dyer and Cepko, 2000; Levine et al., 2000) . In vivo, the decrease in PATF expression by injection of the antisense retroviral construct into the eye led to morphological changes, such as dysplasia with retinal infolding and rosette formation. E2F1 and E2F4 are involved in the control of cell proliferation and dierentiation during the neuroretinal development. The down-regulation of E2F1 gene expression is necessary for neuronal terminal dierentiation in avian neuroretina Kastner et al., 1998) . In this system, p105Rb/E2F1 complex disappears when cells stop dividing, whereas the p130/E2F4 complex accumulates in quiescent neuroretina cells . In this context, our results demonstrate a physical association between PATF and E2F4 proteins. Furthermore, we observed that in postmitotic retina, E2F1 is down-regulated whereas E2F4 expression increases and becomes nuclear like PATF. Our results on PC12 cells treated with NGF show that PATF protein becomes nuclear upon NGF dierentiation. In these conditions, E2F4 is also translocated to the nucleus as previously described (Persengiev et al., 1999) . As PATF presents the features of a transcription factor, we performed gel shift assays to determine whether PATF interacts with DNA. Gel retardation assays were carried out with nuclear protein extracts from retinas in quiescent state. Our results demonstrate that PATF interacts with the E2F binding site. This interaction could be through the PATF/E2F4 complex formation which is consistent with their physical association. Moreover, in nuclear extracts of antisense RCAS infected cells PATF/E2F DNA supershift signal was signi®cantly less intense compared to that observed in nuclear extracts of sense RCAS infected cells (data not shown). In addition, when PATF synthesis is decreased, the E2F4 level fell whereas the E2F1 level rose. This up-regulation of E2F1 was followed by transcriptional activation of two E2F1 target genes, DHFR and DNA POLa. These target genes are known to activate cell proliferation, which is consistent with the additional mitosis observed.
Taken together, our results indicate that PATF/ E2F4 could act as an inhibitory complex in quiescent cells preventing the activation of E2F1 gene expression. Thus, PATF might be a new molecular signal involved in the regulation of cell cycle withdrawal at the terminal cell dierentiation.
Materials and methods
Northern blot and RT ± PCR analyses
Total RNAs were isolated by the guanidium/thiocyanate method (Chirgwin et al., 1979) . Northern blots were performed as described (Maniatis et al., 1989) with 15 mg per lane of total mRNAs. RT ± PCR were performed using the oligonucleotide primers: for PATF, 5'-TCCTATGCTT-GACTATTAGC-3' and 5'-TACAGCTGCTGGGAGCTGG-3' at 548C for 30 cycles. The 32 P-labeled oligonucleotide used as internal probe for the PCR product corresponding to a 254 bp fragment of the PATF coding region was: 5'-CCTGACATCCCTACATCACCGCAT-3'.
For dihydrofolate reductase (DHFR) and DNA polymerase a (DNA POLa) gene expression were performed as described by Vigo et al. (1999) . For GAPDH, 5'-ATGCCCC-CATGTTTGTGATG-3' and 5'-ATGGCATGGACTGTG-GTCAT-3' at 548C for 30 cycles, ampli®cation products were probed with 5'-GCTGACAATCTTGAGGGAGTTGT-CATATTT-3'.
Figure 8 PATF antibody supershift assays in chick retina. Gel mobility shift assays using C/EBP and E2F binding sites were performed with nuclear extracts from retina tissue at E17, without (lanes 1 and 3) or with corresponding competitors (lanes 2 and 5) and with the anti-PATF antibody (lanes 3 and 6). Controls were done with E17 nuclear extracts in the presence of the E2F probe incubated with preimmune serum (lane 7) or with an anti-GFAP (lane 8). In the presence of the anti-PATF antibody, a supershift was observed only when the E2F sequence was used (lane 6). An * indicates putative free CEB/P or E2F or non speci®c bands PATF antibody PATF serum was produced by CovalAb (Research and Development in Biotechnology) against three synthetic peptides based on the amino acid sequence of PATF deduced from the cDNA: VTLSAQGRGT, YGPLTNPKPQ and RTLLLPAVSR. Peptides were coupled to keyhole limpet hemocyanin and were used for rabbit immunization.
RCAS vector constructs and virus production
We inserted into the unique ClaI site of the (RCAS) vector (Hughes et al., 1987) , a 652 bp fragment of the PATF sequence containing the ATG initiator in antisense orientation or in sense as control. RCAS cloned retroviral DNAs (7 mg) were used to transfect chick embryo ®broblasts (2610 5 cells/cm 2 in 25 cm 2¯a sk) by overnight calcium phosphate precipitation to produce virus. Concentrated viruses were used to infect primary cultures of E6 neuroretina cells (Crisanti-Combes et al., 1982; Crisanti et al., 1985) or for injection into chicken eyes at E4.5. Cell cultures or injected eyes were analysed 10 days after infection using: anti-p27 gag antibody to detect the virus (1/1000 in PBS 0.1% Triton X-100), anti-PATF (1 : 100 in PBS 0.1% Triton X-100) and mouse monoclonal anti-BrdU (FITC Becton Dickinson 1/10 in PBS, 0.5% Tween 20) antibodies.
Quantification of BrdU positive cells
Six-day-old retina cells infected with S-or AS-RCAS in Eagle Basal culture medium (10% fetal calf serum) were analysed for BrdU immunoreactivity. Ten mM BrdU was added 6 h before ®xation. 
Immunohistochemistry and confocal microscopy
Immunohistochemical staining of retinal cryosections (10 mm thick) or dissociated cells was done as described in Omri et al. (1998) . Confocal microscopy and scanning were carried out using an ACAS 570 Interactive laser Cytometer (Meridian Instruments, Inc, Okemos, MI, USA) equiped with confocal optics. The system consisted of a 5W argon ion laser, an Olympus IMT-2 microscope with a 100X oil immersion objective, Z axis control, an XY scanning stage, and a variable spindle aperture, under 80486 computer control.
Cell line cultures
Rat pheochromocytoma cell line (PC12), human neuroblastoma cell line (SH-SY5Y) and human retinoblastoma cells (Y79), were cultured as respectively described (Reid et al., 1974; Biedler et al., 1973) . PC12 cell cultures were incubated with or without 100 ng/ml NGF (b-NGF ref.: 450-01, Pepro Tech. Inc.) for 72 h.
Western blotting and immunoprecipitation
Western blots were performed on retina tissues (50 mg per lane) homogenized in lysis buer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 0.5% NP40, 0.5% Triton X-100 and Boehringer Mannheim protease inhibitor cocktail) as described in Omri et al. (1998) . For immunoprecipitation analysis, 150 ± 200 mg of protein extracts were treated with 5 ml of the appropriate primary antibody and protein A sepharose (3 mg in 100 ml) according to the manufacturer's instructions (Pharmacia). Antibodies were purchased from Santa Cruz Biotechnology: rabbit polyclonal E2F-1 (C20-sc193), rabbit polyclonal E2F-4 (C20-sc866), from Serotec: rat monoclonal atubulin (MCAP77) and from CALTAG: rabbit polyclonal peroxidase conjugated antibodies. Protein concentrations were determined by the Bradford method (Bradford, 1976) .
Electromobility shift assays (EMSAs)
EMSAs were performed as described previously (Rouet et al., 1992) , with E17 retinal nuclear protein extracts (5 mg). Two oligonucleotides were used: the CCAAT/enhancerbinding protein C/EBPa 5'-CTAGGATATTGCGCAA-TATGC-3', and the E2F consensus site 5'-TAGTTTTCGCGCTTAAATTTGA-3'. Binding reactions were performed in 15 ml with a reaction mixture containing 10 mM HEPES buer, pH 7.9, 30 mM KCl, 1 mM MgCl 2 , 9 mM spermidine, 0.5 mM DTT, 10% glycerol, 15 mg polydeoxyinosinic-deoxycytididylic (poly(dI-dC)), and 1 mg of sonicated salmon sperm DNA. Probe supershifts were performed by incubating the reaction mixture for 30 min at 48C with 1 ml of the anti-PATF antibody or preimmune serum or anti-GFAP antibody (®nal dilution 1 : 200). DNA-protein complexes were subjected to electrophoresis in a prerun 5% polyacrylamide gel (29 : 1) in 0.25X TBE. The gels were then dried and autoradiographied.
